andrea necchi, esmo 2019 - keynote-045 trial in advanced urothelial cancer
Published 5 years ago • 725 plays • Length 8:55Download video MP4
Download video MP3
Similar videos
-
3:24
arlene siefker-radtke, esmo 2019 - keynote-866 phase iii trial in bladder cancer
-
9:10
petros grivas, esmo 2019 - advances in metastatic urothelial cancer
-
1:45
dr. rosenberg on the keynote-045 trial in advanced urothelial cancer
-
3:41
julie graff, esmo 2019 - keynote-641 study in prostate cancer
-
3:07
linda mileshkin, esmo 2019 - phase iii outback trial in cervical cancer
-
11:29
enfortumab vedotin plus pembrolizumab: results of the ev-302 trial with thomas powles, md
-
5:05
challenges in treating penile cancer
-
30:20
updates in the management of neuroendocrine cancers
-
4:16
unite: enfortumab vedotin in advanced urothelial cancer
-
0:58
significance of keynote-045 trial of pembrolizumab vs chemotherapy in urothelial carcinoma
-
5:58
interview with dr. andrea necchi about targeted agents for advanced bladder cancer
-
3:06
how effective are adcs in treating metastatic urothelial cancer?
-
5:05
ahmed kaseb, esmo 2019 - nivolumab plus ipilimumab in hcc
-
23:25
bladder cancer: latest advances in targeted therapies and precision medicine from esmo 2019
-
1:09
keynote-045 – pembrolizumab as second-line treatment in urothelial carcinoma
-
2:23
daniel petrylak, emso 2019 - phase iii keynote-321 study in prostate cancer
-
1:18
dr. plimack on keynote-045 trial for pembrolizumab in urothelial carcinoma
-
2:41
firstline pembrolizumab for metastatic urothelial cancer
-
1:29:54
examining the state of the science on new therapies in bladder cancer
-
7:01:25
4th indooncology summit-2022 | day 1